<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <title>Testosterone Research News</title>
        <description>Recent findings from the most important testosterone studies around the world</description>
        <link>http://www.nebido.com</link>
        <lastBuildDate>Fri, 18 May 2012 20:22:35 +0100</lastBuildDate>
        <item>
            <title>How long do the benefits of testosterone replacement therapy take to appear and reach a peak?</title>
            <link>http://www.nebido.com/how-long-do-the-benefits-of-testosterone-replacement-therapy-take-to-appear-and-reach-a-peak?WT.rss_f=patient&amp;WT.rss_a=How long do the benefits of testosterone replacement therapy take to appear and reach a peak?&amp;WT.rss_ev=a</link>
            <description>The benefits of testosterone replacement therapy in men with low testosterone (also known as hypogonadism) have been extensively studied. However, the same level of attention has not been given to understanding the time-course of testosterone effects in men receiving treatment. This article reviewed studies of testosterone replacement therapy to better understand the time-course for the start of treatment effects and the length of time required to reach maximum benefits.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/how-long-do-the-benefits-of-testosterone-replacement-therapy-take-to-appear-and-reach-a-peak?WT.rss_f=patient&amp;WT.rss_a=How long do the benefits of testosterone replacement therapy take to appear and reach a peak?&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Mon, 16 Apr 2012 09:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/how-long-do-the-benefits-of-testosterone-replacement-therapy-take-to-appear-and-reach-a-peak?WT.rss_f=patient&amp;WT.rss_a=How long do the benefits of testosterone replacement therapy take to appear and reach a peak?&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Current state of knowledge on low testosterone in middle-aged and older men</title>
            <link>http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&amp;WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&amp;WT.rss_ev=a</link>
            <description>This article reviewed what is known about the consequences of low testosterone (also known as hypogonadism) in middle-aged and older men, with practical information on the benefits and risks of testosterone replacement. The authors examined evidence from a wide range of studies about low testosterone and its treatment to prepare their review.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&amp;WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Mon, 02 Apr 2012 09:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/current-state-of-knowledge-on-low-testosterone-in-middle-aged-and-older-men?WT.rss_f=patient&amp;WT.rss_a=Current state of knowledge on low testosterone in middle-aged and older men&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Link between low testosterone and frailty in elderly men</title>
            <link>http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&amp;WT.rss_a=Link between low testosterone and frailty in elderly men&amp;WT.rss_ev=a</link>
            <description>This review discussed the relationship between low testosterone level and frailty in elderly men and evaluated the evidence which shows that testosterone replacement therapy improves the physical functioning and quality of life of elderly frail men with confirmed low testosterone levels.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&amp;WT.rss_a=Link between low testosterone and frailty in elderly men&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Thu, 08 Mar 2012 09:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/link-between-low-testosterone-and-frailty-in-elderly-men?WT.rss_f=patient&amp;WT.rss_a=Link between low testosterone and frailty in elderly men&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone injection, but not oral testosterone, effective in men with low testosterone and metabolic syndrome or diabetes</title>
            <link>http://www.nebido.com/testosterone-injection-but-not-oral-testosterone-effective-in-men-with-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection, but not oral testosterone, effective in men with low testosterone and metabolic syndrome or diabetes&amp;WT.rss_ev=a</link>
            <description>This study compared the effects of the long-acting testosterone undecanoate injection with those of oral testosterone undecanoate capsules in 52 men (mean age 57 years) with hypogonadism (low testosterone) and symptoms of the metabolic syndrome (MetS) and/or type 2 diabetes mellitus. For the first 6 months of the study, two similar groups of men received either the testosterone injection every 12 weeks or testosterone undecanoate capsules twice daily. There was a third, control, group of men who received a dummy drug (placebo). After 6 months, the oral testosterone group was switched over to receive 6 months of treatment with the testosterone injection, while the other groups continued with their original treatment for another 6 months.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-injection-but-not-oral-testosterone-effective-in-men-with-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection, but not oral testosterone, effective in men with low testosterone and metabolic syndrome or diabetes&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Thu, 01 Dec 2011 09:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-injection-but-not-oral-testosterone-effective-in-men-with-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection, but not oral testosterone, effective in men with low testosterone and metabolic syndrome or diabetes&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone injection improves sexual function in Korean men with low testosterone and erectile dysfunction</title>
            <link>http://www.nebido.com/testosterone_injection_improves_sexual_function_in_korean_men_with_low_testosterone_and_erectile_dysfunction?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection improves sexual function in Korean men with low testosterone and erectile dysfunction&amp;WT.rss_ev=a</link>
            <description>&lt;p&gt;Testosterone replacement therapy with the long-acting injection formulation of testosterone undecanoate has been shown to return testosterone levels to normal and improve erectile function in European men with low testosterone (also known as hypogonadism) and erectile dysfunction (ED). However, there has been little information about how safe and effective the testosterone undecanoate injection is in Asian men. This study treated 133 Korean patients aged 42 to 75 years (average age 54 years) who had ED and low testosterone. The men received a series of three testosterone undecanoate injections; one at the start of the study then again after 6 and 18 weeks.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone_injection_improves_sexual_function_in_korean_men_with_low_testosterone_and_erectile_dysfunction?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection improves sexual function in Korean men with low testosterone and erectile dysfunction&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Tue, 28 Jun 2011 19:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone_injection_improves_sexual_function_in_korean_men_with_low_testosterone_and_erectile_dysfunction?WT.rss_f=patient&amp;WT.rss_a=Testosterone injection improves sexual function in Korean men with low testosterone and erectile dysfunction&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Evidence-based criteria for diagnosing low testosterone in aging men defined</title>
            <link>http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&amp;WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&amp;WT.rss_ev=a</link>
            <description>&lt;p&gt;This study, published in the &lt;em&gt;New England Journal of Medicine&lt;/em&gt;, identified the most important symptoms linked to late-onset hypogonadism (low testosterone levels in aging men) in a large group of men representative of the general population. When testosterone levels were also taken into consideration, having these three symptoms and low testosterone levels was a specific diagnosis of late-onset hypogonadism.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&amp;WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Wed, 08 Jun 2011 19:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/evidence-based-criteria-for-diagnosing-low-testosterone-in-aging-men-defined?WT.rss_f=patient&amp;WT.rss_a=Evidence-based criteria for diagnosing low testosterone in aging men defined&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone replacement therapy improves the effectiveness of treatment for erectile dysfunction in men with low testosterone</title>
            <link>http://www.nebido.com/testosterone-replacement-therapy-improves-the-effectiveness-of-treatment?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves the effectiveness of treatment for erectile dysfunction in men with low testosterone&amp;WT.rss_ev=a</link>
            <description>&lt;p&gt;The TADTEST study examined whether adding testosterone replacement therapy could improve sexual function in men with erectile dysfunction (ED) who had not responded to the PDE5 inhibitor tadalafil, a prescription drug used to treat ED. It also investigated the effect that testosterone levels had on response to a PDE5 inhibitor to see if there was a threshold value for testosterone therapy to improve the effectiveness of PDE5 inhibitor therapy.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-replacement-therapy-improves-the-effectiveness-of-treatment?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves the effectiveness of treatment for erectile dysfunction in men with low testosterone&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Fri, 20 May 2011 19:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-replacement-therapy-improves-the-effectiveness-of-treatment?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves the effectiveness of treatment for erectile dysfunction in men with low testosterone&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone replacement therapy improves glucose control and reduces central obesity in men with metabolic syndrome and low testosterone</title>
            <link>http://www.nebido.com/testosterone-replacement-therapy-improves-glucose-control-and-reduces-central-obesity?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves glucose control and reduces central obesity in men with metabolic syndrome and low testosterone&amp;WT.rss_ev=a</link>
            <description>&lt;p&gt;This study carefully evaluated available good quality studies that compared the levels of testosterone in men with or without the metabolic syndrome to see if metabolic syndrome is linked to low testosterone. The study also looked at the effects of testosterone replacement therapy on components of the metabolic syndrome.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-replacement-therapy-improves-glucose-control-and-reduces-central-obesity?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves glucose control and reduces central obesity in men with metabolic syndrome and low testosterone&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Thu, 05 May 2011 19:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-replacement-therapy-improves-glucose-control-and-reduces-central-obesity?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy improves glucose control and reduces central obesity in men with metabolic syndrome and low testosterone&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone replacement therapy reduces visceral fat and waist circumference and counteracts cardiovascular risk factors in men with low testosterone and metabolic syndrome</title>
            <link>http://www.nebido.com/testosterone-replacement-therapy-reduces-visceral-fat-and-waist-circumference?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy reduces visceral fat and waist circumference and counteracts cardiovascular risk factors in men with low testosterone and metabolic syndrome&amp;WT.rss_ev=a</link>
            <description>&lt;p&gt;The aim of this study was to examine whether long-term testosterone replacement therapy could help improve risk factors for heart disease and reduce narrowing of the arteries in men with low testosterone levels who also had metabolic syndrome and/or type 2 diabetes.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-replacement-therapy-reduces-visceral-fat-and-waist-circumference?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy reduces visceral fat and waist circumference and counteracts cardiovascular risk factors in men with low testosterone and metabolic syndrome&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Thu, 21 Apr 2011 17:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-replacement-therapy-reduces-visceral-fat-and-waist-circumference?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy reduces visceral fat and waist circumference and counteracts cardiovascular risk factors in men with low testosterone and metabolic syndrome&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone</title>
            <link>http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&amp;WT.rss_ev=a</link>
            <description>There is increasing evidence that erectile dysfunction may be a warning sign of a number of disease conditions, such as high blood pressure, metabolic syndrome, diabetes mellitus, depression and coronary heart disease.&lt;br/&gt;&lt;br/&gt;Nearly 1700 men attending an andrology clinic for erectile dysfunction were monitored for an average of 4.3 years to find out whether those with low testosterone levels were more likely to suffer a major cardiovascular disease event, such as a heart attack or stroke.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Fri, 01 Apr 2011 17:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/increased-risk-of-dying-from-cardiovascular-disease-for-men-with-ed-and-low-testosterone?WT.rss_f=patient&amp;WT.rss_a=Increased risk of dying from cardiovascular disease for men with erectile dysfunction and low testosterone&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Low testosterone is common in men with cardiovascular disease and decreases survival</title>
            <link>http://www.nebido.com/low-testosterone-is-common-in-men-with-cardiovascular-disease-and-decreases-survival?WT.rss_f=patient&amp;WT.rss_a=Low testosterone is common in men with cardiovascular disease and decreases survival&amp;WT.rss_ev=a</link>
            <description>A study in the United Kingdom observed 930 men with confirmed coronary artery disease over an average of nearly 7 years to find out how many had testosterone deficiency and to examine whether low testosterone affected survival. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/low-testosterone-is-common-in-men-with-cardiovascular-disease-and-decreases-survival?WT.rss_f=patient&amp;WT.rss_a=Low testosterone is common in men with cardiovascular disease and decreases survival&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Fri, 11 Mar 2011 15:30:00 +0100</pubDate>
            <guid>http://www.nebido.com/low-testosterone-is-common-in-men-with-cardiovascular-disease-and-decreases-survival?WT.rss_f=patient&amp;WT.rss_a=Low testosterone is common in men with cardiovascular disease and decreases survival&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Norwegian study shows supplementary testosterone reduces fat and improves hip bone density in elderly men with low Testosterone levels</title>
            <link>http://www.nebido.com/supplementary-testosterone-reduces-fat-and-improves-hip-bone-density-norwegian-study?WT.rss_f=patient&amp;WT.rss_a=Norwegian study shows supplementary testosterone reduces fat and improves hip bone density in elderly men with low Testosterone levels&amp;WT.rss_ev=a</link>
            <description>In 2008 the International Journal of Impotence Research published a Norwegian study that examined whether lower than normal levels of the hormone testosterone in elderly men (average age 69) were linked to a reduced quality of life and physical and mental health. Researchers also studied whether treatment with supplementary testosterone could improve these conditions.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/supplementary-testosterone-reduces-fat-and-improves-hip-bone-density-norwegian-study?WT.rss_f=patient&amp;WT.rss_a=Norwegian study shows supplementary testosterone reduces fat and improves hip bone density in elderly men with low Testosterone levels&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Tue, 22 Feb 2011 11:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/supplementary-testosterone-reduces-fat-and-improves-hip-bone-density-norwegian-study?WT.rss_f=patient&amp;WT.rss_a=Norwegian study shows supplementary testosterone reduces fat and improves hip bone density in elderly men with low Testosterone levels&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Diet and exercise plus testosterone improves glucose control in men with low testosterone and newly diagnosed Type 2 Diabetes</title>
            <link>http://www.nebido.com/men-with-newly-diagnosed-type-2-diabetes-testosterone-with-diet-and-exercise-reverses-mets?WT.rss_f=patient&amp;WT.rss_a=Diet and exercise plus testosterone improves glucose control in men with low testosterone and newly diagnosed Type 2 Diabetes&amp;WT.rss_ev=a</link>
            <description>At the end of 2009 the American Journal of Andrology published the results of a clinical trial investigating the effects of diet and exercise (D&amp;E) with and without the addition of testosterone given as gel absorbed through the skin, on 32 men with lower than normal levels of testosterone, and with recently diagnosed Type 2 Diabetes and indicators of potential heart disease (Metabolic Syndrome).&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/men-with-newly-diagnosed-type-2-diabetes-testosterone-with-diet-and-exercise-reverses-mets?WT.rss_f=patient&amp;WT.rss_a=Diet and exercise plus testosterone improves glucose control in men with low testosterone and newly diagnosed Type 2 Diabetes&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Wed, 19 Jan 2011 12:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/men-with-newly-diagnosed-type-2-diabetes-testosterone-with-diet-and-exercise-reverses-mets?WT.rss_f=patient&amp;WT.rss_a=Diet and exercise plus testosterone improves glucose control in men with low testosterone and newly diagnosed Type 2 Diabetes&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone replacement therapy for the treatment of male hypogonadism – results from the largest international study</title>
            <link>http://www.nebido.com/testosterone-replacement-therapy-for-treatment-of-male-hypogonadism-worldwide-largest-study?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy for the treatment of male hypogonadism – results from the largest international study&amp;WT.rss_ev=a</link>
            <description>1493 patients from 23 countries joined this study; of these 1123 completed a series of five injections of supplementary testosterone.&lt;br /&gt;&lt;br /&gt;&lt;img src="/html/images/upload/hcp/therapy/Zitzmann-IPASS-Study.png" alt="Prof. Michael Zitzmann, Germany" /&gt;&lt;br /&gt;&lt;br /&gt;All patients had lower than normal levels of testosterone at the start of treatment. The average age of men taking part was just over 49 years. Some suffered from other conditions such as hypertension (high blood pressure) and diabetes.&lt;br /&gt;&lt;br /&gt;The findings of this study were presented to the Men’s Health World Congress, 2010 held in France.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-replacement-therapy-for-treatment-of-male-hypogonadism-worldwide-largest-study?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy for the treatment of male hypogonadism – results from the largest international study&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Wed, 08 Dec 2010 20:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-replacement-therapy-for-treatment-of-male-hypogonadism-worldwide-largest-study?WT.rss_f=patient&amp;WT.rss_a=Testosterone replacement therapy for the treatment of male hypogonadism – results from the largest international study&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Supplementary testosterone helps men with angina to exercise for longer</title>
            <link>http://www.nebido.com/supplementary-testosterone-helps-men-with-angina-to-exercise-for-longer?WT.rss_f=patient&amp;WT.rss_a=Supplementary testosterone helps men with angina to exercise for longer&amp;WT.rss_ev=a</link>
            <description>A clinical study published in the European Journal of Endocrinology has shown that treatment (injections) with supplementary testosterone (Nebido®) enabled men with low testosterone levels who suffer from angina to exercise for longer before feeling uncomfortable.&lt;br /&gt;&lt;br /&gt;Men in the group also lost weight, although not to a significant extent, compared to a similar, well matched group of men not receiving the treatment (the placebo group).&lt;br /&gt;&lt;br /&gt;This is the longest study investigating testosterone therapy in patients with long term (or chronic) angina.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/supplementary-testosterone-helps-men-with-angina-to-exercise-for-longer?WT.rss_f=patient&amp;WT.rss_a=Supplementary testosterone helps men with angina to exercise for longer&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Tue, 09 Nov 2010 18:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/supplementary-testosterone-helps-men-with-angina-to-exercise-for-longer?WT.rss_f=patient&amp;WT.rss_a=Supplementary testosterone helps men with angina to exercise for longer&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Boosting testosterone improves mood and other 'quality of life' measures in older men</title>
            <link>http://www.nebido.com/boosting-testosterone-improves-mood-and-other-quality-of-life-measures-in-older-men?WT.rss_f=patient&amp;WT.rss_a=Boosting testosterone improves mood and other 'quality of life' measures in older men&amp;WT.rss_ev=a</link>
            <description>A Russian study, published in the Journal of Sexual Medicine in July 2010, looked at how men with metabolic syndrome (Met S) and hypogonadism responded to treatment with either a placebo (safe, dummy medicine) or testosterone (Nebido®) injections.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Key findings&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;Following treatment with additional testosterone (Nebido®) to reach 'normal' testosterone levels, men in the trial (average age 51) reported feeling and functioning better. They also lost weight. These improvements to quality of life measures were significantly better than the results achieved by the placebo.&lt;br /&gt;&lt;br /&gt;The most significant improvements to quality of life scores were reported by those men who had the lowest levels of testosterone at the start of the study.&lt;br /&gt;&lt;br /&gt;Patients felt better and functioned better when they lost weight and the more weight they lost, the more they improved.&lt;br /&gt;&lt;br /&gt;The study suggests that testosterone supplementation alone may improve depression in men with Met S and hypogonadism.&lt;br /&gt;&lt;br /&gt;There were no health issues associated with the testosterone therapy.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/boosting-testosterone-improves-mood-and-other-quality-of-life-measures-in-older-men?WT.rss_f=patient&amp;WT.rss_a=Boosting testosterone improves mood and other 'quality of life' measures in older men&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Thu, 28 Oct 2010 17:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/boosting-testosterone-improves-mood-and-other-quality-of-life-measures-in-older-men?WT.rss_f=patient&amp;WT.rss_a=Boosting testosterone improves mood and other 'quality of life' measures in older men&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years</title>
            <link>http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&amp;WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&amp;WT.rss_ev=a</link>
            <description>Aging is associated with a reduction in testosterone levels in the blood. This reduction causes a number of symptoms, one of which is losing muscle mass.&lt;br /&gt;&lt;br /&gt;This small, well-designed 12-month study looked at the effect of the testosterone patch on body composition and hormones in 60 men aged ≥55 years who were healthy and not obese, and who had low-to-normal testosterone levels and typical testosterone deficiency symptoms. Blood testosterone levels increased in patients receiving the testosterone patch and decreased in patients receiving placebo. Fat-free mass and skeletal muscle mass increased in the testosterone group but did not change in the placebo group (Figure). Fat mass decreased with testosterone and increased with placebo; these changes were linked to changes in blood testosterone levels.&lt;br /&gt;&lt;br /&gt;The testosterone patch was shown to be safe but one-third of patients left the study early. The main reason for leaving the study was skin irritation.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&amp;WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Tue, 14 Sep 2010 11:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-reduces-fat-and-increases-muscle-mass-in-non-obese-men-aged-55-years?WT.rss_f=patient&amp;WT.rss_a=Testosterone reduces fat and increases muscle mass in non-obese men aged ≥55 years&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title>Testosterone improves symptoms in elderly men with chronic heart failure</title>
            <link>http://www.nebido.com/testosterone-improves-symptoms-in-elderly-men-with-chronic-heart-failure?WT.rss_f=patient&amp;WT.rss_a=Testosterone improves symptoms in elderly men with chronic heart failure&amp;WT.rss_ev=a</link>
            <description>Chronic heart failure (CHF) is a medical condition where the heart cannot pump enough blood around the body. This can lead to muscle weakness. Common symptoms include shortness of breath and inability to exercise. Many patients with CHF also have low testosterone levels and studies have suggested that testosterone treatment may improve some symptoms of CHF.&lt;br /&gt;&lt;br /&gt;This well designed study looked at the benefits of long-acting (injected) testosterone in elderly men with CHF. After only 12 weeks of treatment (3 injections) there were marked improvements in muscle strength and ability to exercise that were not seen in patients who received a sham injection (placebo group). In addition, testosterone treatment led to an improvement in the way the body uses insulin (important in metabolic syndrome and type II diabetes).&lt;br /&gt;&lt;br /&gt;Testosterone treatment was found to be safe in these frail patients who were already receiving multiple medications for heart failure.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.nebido.com/testosterone-improves-symptoms-in-elderly-men-with-chronic-heart-failure?WT.rss_f=patient&amp;WT.rss_a=Testosterone improves symptoms in elderly men with chronic heart failure&amp;WT.rss_ev=a"&gt;Read more&lt;/a&gt;&lt;br /&gt;</description>
            <author>menshealthcare@bayerhealthcare.com</author>
            <pubDate>Tue, 10 Aug 2010 13:00:00 +0100</pubDate>
            <guid>http://www.nebido.com/testosterone-improves-symptoms-in-elderly-men-with-chronic-heart-failure?WT.rss_f=patient&amp;WT.rss_a=Testosterone improves symptoms in elderly men with chronic heart failure&amp;WT.rss_ev=a</guid>
        </item>
        <item>
            <title> </title>
            <link>http://www.nebido.com</link>
            <description>&lt;img src="http://statse.webtrendslive.com/dcs731jyzvz5bdmvsxj67por1_7j4d/dcs.gif?dcsdat=1337372555920&amp;dcssip=www.nebido.com&amp;dcsuri=%2Fscripts%2Fcomponents%2Fnewslist%2Fen%2Fpatients.php&amp;dcscfg=1&amp;WT.dl=10&amp;WT.rss_f=patient&amp;WT.rss_ev=sv&amp;WT.ti=patient" /&gt;</description>
            <pubDate>Sat, 01 Jan 2000 13:00:00 +0100</pubDate>
        </item>
    </channel>
</rss>

